These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33005047)

  • 1. Comment on "New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy".
    Xiao G; Li AS
    Eye (Lond); 2021 Oct; 35(10):2903-2904. PubMed ID: 33005047
    [No Abstract]   [Full Text] [Related]  

  • 2. New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy.
    Saw M; Wong VW; Ho IV; Liew G
    Eye (Lond); 2019 Dec; 33(12):1842-1851. PubMed ID: 31227789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic management of diabetic retinopathy.
    Liew G; Mitchell P; Wong TY
    BMJ; 2009 Feb; 338():b441. PubMed ID: 19213762
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of insulin therapy on progression of retinopathy in noninsulin-dependent diabetes mellitus.
    Roysarkar TK; Gupta A; Dash RJ; Dogra MR
    Am J Ophthalmol; 1993 May; 115(5):569-74. PubMed ID: 8488908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.
    Rosenstock J; Fonseca V; McGill JB; Riddle M; Hallé JP; Hramiak I; Johnston P; Davis M
    Diabetologia; 2009 Sep; 52(9):1778-88. PubMed ID: 19526210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plan of action. Customizing your diabetes management puts you in control.
    Neithercott T
    Diabetes Forecast; 2012 Apr; 65(4):49-53. PubMed ID: 22582525
    [No Abstract]   [Full Text] [Related]  

  • 7. Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy.
    Cho EH; Park SJ; Han S; Song JH; Lee K; Chung YR
    J Diabetes Res; 2018; 2018():6807219. PubMed ID: 30622970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinopathy progression in type 2 diabetes.
    Morita H; Nagai R
    N Engl J Med; 2010 Nov; 363(22):2171; author reply 2173-4. PubMed ID: 21105810
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug therapy regimens in diabetic retinopathy].
    Mitulescu D; Selaru D; Ocian R
    Oftalmologia; 1999; 46(1):63-6. PubMed ID: 10641089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic retinopathy and insulin glargine.
    Chantelau E
    Diabetologia; 2009 Oct; 52(10):2233; author reply 2236-9. PubMed ID: 19680626
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction in risk of progression of diabetic retinopathy.
    Klein BE
    N Engl J Med; 2010 Jul; 363(3):287-8. PubMed ID: 20587586
    [No Abstract]   [Full Text] [Related]  

  • 12. Vision related quality of life in patients with type 2 diabetes in the EUROCONDOR trial.
    Trento M; Durando O; Lavecchia S; Charrier L; Cavallo F; Costa MA; Hernández C; Simó R; Porta M;
    Endocrine; 2017 Jul; 57(1):83-88. PubMed ID: 27628581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme.
    Sjølie AK; Klein R; Porta M; Orchard T; Fuller J; Parving HH; Bilous R; Aldington S; Chaturvedi N
    Diabet Med; 2011 Mar; 28(3):345-51. PubMed ID: 21309844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence and risk factors for diabetic retinopathy in type 2 diabetes patients in Jewish and Bedouin populations in southern Israel].
    Chorny A; Lifshits T; Kratz A; Levy J; Golfarb D; Zlotnik A; Knyazer B
    Harefuah; 2011 Dec; 150(12):906-10, 935. PubMed ID: 22352283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor glycaemic control and retinopathy in non-insulin-dependent diabetes mellitus.
    Bastyr EJ; Janes J; Barnett AH
    Diabet Med; 1997 Nov; 14(11):993-4. PubMed ID: 9400930
    [No Abstract]   [Full Text] [Related]  

  • 16. A dramatic deterioration in diabetic retinopathy with improvement in glycated haemoglobin (HbA(1c)) on exenatide treatment.
    Brooks AM; Lissett CA
    Diabet Med; 2009 Feb; 26(2):190. PubMed ID: 19236627
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Stratton IM; Matthews DR
    Diabet Med; 1997 Aug; 14(8):709-10. PubMed ID: 9272603
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on systemic management of diabetes.
    Masharani U; Rushakoff RJ
    Int Ophthalmol Clin; 2009; 49(2):13-33. PubMed ID: 19349784
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of proliferative diabetic retinopathy with insulin use and microalbuminuria.
    Chu SH; Li AH
    Arch Ophthalmol; 2010 Jan; 128(1):146; author reply 146-7. PubMed ID: 20065240
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucagon-like peptide-1 (GLP-1) receptor agonists in type 2 diabetes and long-term complications: FOCUS on retinopathy.
    Marchand L; Luyton C; Bernard A
    Diabet Med; 2021 Jan; 38(1):e14390. PubMed ID: 32799379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.